Ch Milde Fils & Industrielle Socit Anonyme competitive analysis

Explore patent oppositions filed by Ch Milde Fils & Industrielle Socit Anonyme against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
Beta-1,3'-Galactosyllactose For The Treatment Of Gut Barrier Function DiseasesNUTRICIAMay 19, 2026
Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYOMay 19, 2026
Lactation Stage Specific Infant NutritionNUTRICIAApr 28, 2026
Flexible High Speed Filling Line For Personalized Beverage Package MixesTHE COCA COLAApr 16, 2026
Pet Polymer With An Anti-Crystallization Comonomer That Can Be Bio-SourcedSOCIT ANONYME DES EAUX MINRALES DEVIAN ET EN ABRG SAEMEApr 9, 2026
Fat Composition And Nutritional Composition Based ThereonFRIESLANDCAMPINA NEDERLANDApr 9, 2026
Liquid Nutritional Composition Suitable For Muscle FunctionNUTRICIAMar 20, 2026
Supporting Activities Of Daily LivingNUTRICIAMar 17, 2026
Native Whey Protein For Improving Intestinal MaturationNUTRICIAFeb 20, 2026
Use Of Akkermansia For Treating Metabolic DisordersCOMPAGNIE GERVAIS DANONEFeb 6, 2026

Latest PTAB cases involving Ch Milde Fils & Industrielle Socit Anonyme

Discover the latest PTAB cases involving Ch Milde Fils & Industrielle Socit Anonyme, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ch Milde Fils & Industrielle Socit Anonyme with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CH MILDE FILS & INDUSTRIELLE SOCIT ANONYME25 - - -
COMPAGNIE GERVAIS DANONE2020 - -
FRESENIUS KABI DEUTSCHLAND12923 - -
NUTRICIA169164 - -